Drug Shortage Report for OXALIPLATIN INJECTION
Report ID | 10599 |
Drug Identification Number | 02436957 |
Brand name | OXALIPLATIN INJECTION |
Common or Proper name | Oxaliplatin Injection |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | OXALIPLATIN |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 20mLV |
ATC code | L01XA |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2017-05-17 |
Estimated end date | 2017-07-28 |
Actual end date | 2017-07-28 |
Shortage status | Resolved |
Updated date | 2017-08-02 |
Company comments | Limited inventory available for our customers |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-05-17 | English | Compare |
v2 | 2017-05-17 | French | Compare |
v3 | 2017-05-18 | English | Compare |
v4 | 2017-06-26 | English | Compare |
v5 | 2017-06-26 | French | Compare |
v6 | 2017-07-18 | English | Compare |
v7 | 2017-07-18 | French | Compare |
v8 | 2017-08-02 | English | Compare |
v9 | 2017-08-02 | French | Compare |
Showing 1 to 9 of 9